Quizartinib Granted Priority Review in the U.S. for Patients with Newly Diagnosed FLT3-ITD Positive Acute Myeloid Leukemia
Submission based on QuANTUM-First results showing quizartinib plus chemotherapy significantly improved overall survival compared to…